| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xeris Biopharma Holdings, Inc. (XERS) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. XERS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 3.16M | $20.30M | - | |
| Other | 1.79M | $11.48M | - | |
| Other | 1.46M | $9.39M | - | |
| Other | 1.19M | $7.67M | -16,667 | |
| Dir | 698.1K | $4.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Edick Paul R | See Remarks | Buy | 20,000 | $2.28 | $45,664.00 | +148.9% | -2.8% | -44.0% | |
| Nov 12, 2021 | Shannon John Patrick Jr53 | See Remarks | Buy | 100,000 | $2.10 | $209,500.00 | +17.6% | +16.4% | -30.8% | |
| Nov 11, 2021 | Edick Paul R | See Remarks | Buy | 200,000 | $2.08 | $415,760.00 | +32.9% | +15.9% | -28.8% | |
| Nov 10, 2021 | Pieper Steven | See Remarks | Buy | 25,000 | $2.00 | $49,917.50 | +15.8% | +24.2% | -21.1% |